Stocktoria
Trevi Therapeutics, Inc. TRVI
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2019-05-07
Trevi Therapeutics, Inc. institutional holders (13F)
| Investor | Shares | Value |
|---|---|---|
| VIKING GLOBAL INVESTORS LP | 3,198,644 | $40.0M |
| CITADEL ADVISORS LLC | 1,353,389 | $16.1M |
| BlackRock Finance, Inc. | 3,135,115 | $9.3M |
| MILLENNIUM MANAGEMENT LLC | 570,971 | $6.8M |
| D. E. Shaw & Co., Inc. | 181,344 | $2.2M |
| TWO SIGMA INVESTMENTS, LP | 38,415 | $458,291 |
| AQR CAPITAL MANAGEMENT LLC | 28,149 | $335,817 |
Source: SEC EDGAR filings · CIK 0001563880 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.